Q8IX03 (KIBRA_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 79.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Protein KIBRA Alternative name(s): HBeAg-binding protein 3 Kidney and brain protein Short name=KIBRA WW domain-containing protein 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1113 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Probable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with NF2 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. Acts as a transcriptional coactivator of ESR1 which plays an essential role in DYNLL1-mediated ESR1 transactivation. Regulates collagen-stimulated activation of the ERK/MAPK cascade. Modulates directional migration of podocytes. Acts as a substrate for PRKCZ and may be associated with memory performance. Ref.8 Ref.9 Ref.12 Ref.13 Ref.14 Ref.16 |
| Subunit structure | Homodimer. Interacts with DDN. Interacts with DYNLL1 and histone H3. The interaction with DYNLL1 is mandatory for the recruitment and transactivation functions of ESR1 or DYNLL1 to the target chromatin and the interaction with histone H3 ensures proper regulatory interaction of WWC1-DYNLL1-ESR1 complexes with target chromatin. Interacts (via WW domains) with DDR1 (via PPxY motif) in a collagen-regulated manner. Interacts with PRKCZ (via the protein kinase domain). Forms a tripartite complex with DDR1 and PRKCZ, but predominantly in the absence of collagen. Interacts (via the ADDV motif) with INADL (via PDZ domain 8). Interacts (via WW domains) with SYNPO (via PPxY motifs). Interacts with NF2 and SNX4. Ref.1 Ref.8 Ref.9 Ref.11 Ref.12 Ref.13 Ref.14 Ref.17 |
| Subcellular location | Cytoplasm. Cytoplasm › perinuclear region. Nucleus. Cell projection › ruffle membrane. Note: Co-localizes with PRKCZ in the perinuclear region. Ref.1 Ref.9 Ref.12 Ref.13 |
| Tissue specificity | Expressed in mammary epithelial cells and breast cancer cell lines. Found in the luminal epithelium surrounding the ducts in the normal breast. In the brain, expressed in somatodendritic compartment of neurons in the cortex and hippocampus and in the cerebellum it is found in the Purkinje cells and some granule cells (at protein level). Detected in brain, heart, colon and kidney. In the kidney, expressed in glomerular podocytes, in some tubules and in the collecting duct. Ref.1 Ref.12 Ref.13 Ref.14 |
| Induction | Strongly up-regulated by progestin treatment. Ref.13 |
| Domain | The C2-domain mediates homodimerization. Ref.14 |
| Sequence similarities | Belongs to the WWC family. KIBRA subfamily. Contains 1 C2 domain. Contains 2 WW domains. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q8IX03-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q8IX03-2) The sequence of this isoform differs from the canonical sequence as follows: 974-974: S → SPPPQPS |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1113 | 1113 | Protein KIBRA | PRO_0000242153 | ||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||
| Domain | 6 – 39 | 34 | WW 1 | |||||||||||||||||||||||||||
| Domain | 53 – 86 | 34 | WW 2 | |||||||||||||||||||||||||||
| Domain | 655 – 783 | 129 | C2 | |||||||||||||||||||||||||||
| Region | 839 – 1113 | 275 | Interaction with histone H3 | |||||||||||||||||||||||||||
| Region | 953 – 996 | 44 | Interaction with PRKCZ | |||||||||||||||||||||||||||
| Coiled coil | 107 – 193 | 87 | Potential | |||||||||||||||||||||||||||
| Coiled coil | 293 – 431 | 139 | Potential | |||||||||||||||||||||||||||
| Coiled coil | 1001 – 1032 | 32 | Potential | |||||||||||||||||||||||||||
| Motif | 1111 – 1113 | 3 | ADDV motif | |||||||||||||||||||||||||||
| Compositional bias | 261 – 265 | 5 | Poly-Ser | |||||||||||||||||||||||||||
| Compositional bias | 819 – 873 | 55 | Glu-rich | |||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||
| Modified residue | 899 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||
| Modified residue | 912 | 1 | Phosphothreonine Ref.15 | |||||||||||||||||||||||||||
| Modified residue | 922 | 1 | Phosphoserine Ref.10 | |||||||||||||||||||||||||||
| Modified residue | 923 | 1 | Phosphothreonine Ref.10 | |||||||||||||||||||||||||||
| Modified residue | 927 | 1 | Phosphoserine Ref.10 | |||||||||||||||||||||||||||
| Modified residue | 929 | 1 | Phosphothreonine Ref.15 | |||||||||||||||||||||||||||
| Modified residue | 931 | 1 | Phosphoserine Ref.15 | |||||||||||||||||||||||||||
| Modified residue | 975 | 1 | Phosphoserine; by PKC/PRKCZ Ref.8 | |||||||||||||||||||||||||||
| Modified residue | 978 | 1 | Phosphoserine; by PKC/PRKCZ Ref.8 | |||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||
| Alternative sequence | 974 | 1 | S → SPPPQPS in isoform 2. | VSP_019448 | ||||||||||||||||||||||||||
| Natural variant | 250 | 1 | R → C. Corresponds to variant rs17551608 [ dbSNP | Ensembl ]. | VAR_026844 | ||||||||||||||||||||||||||
| Natural variant | 734 | 1 | M → I. Corresponds to variant rs3822660 [ dbSNP | Ensembl ]. | VAR_053449 | ||||||||||||||||||||||||||
| Natural variant | 735 | 1 | S → A. Corresponds to variant rs3822659 [ dbSNP | Ensembl ]. | VAR_053450 | ||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||
| Sequence conflict | 561 | 1 | F → L in CAE45903. Ref.4 | |||||||||||||||||||||||||||
| Sequence conflict | 759 | 1 | C → R in CAE45903. Ref.4 | |||||||||||||||||||||||||||
| Sequence conflict | 811 | 1 | T → TVSWDQ in AAO73817. Ref.6 | |||||||||||||||||||||||||||
| Sequence conflict | 834 | 1 | S → N in CAE45903. Ref.4 | |||||||||||||||||||||||||||
| Sequence conflict | 865 | 1 | Missing in AAO73817. Ref.6 | |||||||||||||||||||||||||||
| Sequence conflict | 1051 | 1 | Missing in CAE45903. Ref.4 | |||||||||||||||||||||||||||
| Sequence conflict | 1051 | 1 | Missing in BAA74892. Ref.5 | |||||||||||||||||||||||||||
| Sequence conflict | 1064 – 1065 | 2 | DK → AR in AAO73817. Ref.6 | |||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||
| Beta strand | 660 – 669 | 10 | ||||||||||||||||||||||||||||
| Turn | 670 – 673 | 4 | ||||||||||||||||||||||||||||
| Beta strand | 674 – 683 | 10 | ||||||||||||||||||||||||||||
| Helix | 685 – 687 | 3 | ||||||||||||||||||||||||||||
| Beta strand | 694 – 704 | 11 | ||||||||||||||||||||||||||||
| Helix | 708 – 711 | 4 | ||||||||||||||||||||||||||||
| Beta strand | 712 – 714 | 3 | ||||||||||||||||||||||||||||
| Beta strand | 722 – 733 | 12 | ||||||||||||||||||||||||||||
| Helix | 736 – 741 | 6 | ||||||||||||||||||||||||||||
| Beta strand | 743 – 751 | 9 | ||||||||||||||||||||||||||||
| Beta strand | 757 – 766 | 10 | ||||||||||||||||||||||||||||
| Beta strand | 777 – 784 | 8 | ||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Characterization of KIBRA, a novel WW domain-containing protein." Kremerskothen J., Plaas C., Buether K., Finger I., Veltel S., Matanis T., Liedtke T., Barnekow A. Biochem. Biophys. Res. Commun. 300:862-867(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH DDN, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Brain. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Thalamus. |
| [3] | "The DNA sequence and comparative analysis of human chromosome 5." Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S. Rubin E.M.Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 36-1113 (ISOFORM 2). Tissue: Fetal brain. |
| [5] | "Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. DNA Res. 5:355-364(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 225-1113 (ISOFORM 2). Tissue: Brain. |
| [6] | "Screening and cloning of interaction protein 3 of HBeAg." Lu Y., Liu Y., Cheng J. Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 202-1113 (ISOFORM 1). Tissue: Liver. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 782-1113 (ISOFORM 1). Tissue: Liver and Placenta. |
| [8] | "KIBRA is a novel substrate for protein kinase Czeta." Buether K., Plaas C., Barnekow A., Kremerskothen J. Biochem. Biophys. Res. Commun. 317:703-707(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBUNIT, INTERACTION WITH PRKCZ, PHOSPHORYLATION AT SER-975 AND SER-978. |
| [9] | "Essential role of KIBRA in co-activator function of dynein light chain 1 in mammalian cells." Rayala S.K., den Hollander P., Manavathi B., Talukder A.H., Song C., Peng S., Barnekow A., Kremerskothen J., Kumar R. J. Biol. Chem. 281:19092-19099(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION, INTERACTION WITH DYNLL1 AND HISTONE H3. |
| [10] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-922; THR-923 AND SER-927, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "SNX4 coordinates endosomal sorting of TfnR with dynein-mediated transport into the endocytic recycling compartment." Traer C.J., Rutherford A.C., Palmer K.J., Wassmer T., Oakley J., Attar N., Carlton J.G., Kremerskothen J., Stephens D.J., Cullen P.J. Nat. Cell Biol. 9:1370-1380(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SNX4. |
| [12] | "KIBRA modulates directional migration of podocytes." Duning K., Schurek E.M., Schlueter M., Bayer M., Reinhardt H.C., Schwab A., Schaefer L., Benzing T., Schermer B., Saleem M.A., Huber T.B., Bachmann S., Kremerskothen J., Weide T., Pavenstaedt H. J. Am. Soc. Nephrol. 19:1891-1903(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SYNPO AND INADL, TISSUE SPECIFICITY. |
| [13] | "KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling." Hilton H.N., Stanford P.M., Harris J., Oakes S.R., Kaplan W., Daly R.J., Ormandy C.J. Biochim. Biophys. Acta 1783:383-393(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION, INDUCTION, INTERACTION WITH DDR1 AND PRKCZ, TISSUE SPECIFICITY. |
| [14] | "Temporal-spatial expression and novel biochemical properties of the memory-related protein KIBRA." Johannsen S., Duning K., Pavenstaedt H., Kremerskothen J., Boeckers T.M. Neuroscience 155:1165-1173(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBUNIT, TISSUE SPECIFICITY, DOMAIN C2. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-912; THR-929 AND SER-931, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded." Yu J., Zheng Y., Dong J., Klusza S., Deng W.-M., Pan D. Dev. Cell 18:288-299(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [17] | "Kibra Is a regulator of the Salvador/Warts/Hippo signaling network." Genevet A., Wehr M.C., Brain R., Thompson B.J., Tapon N. Dev. Cell 18:300-308(2010) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NF2. |
| [18] | "Crystal structure of C2 domain of KIBRA protein." RIKEN structural genomics initiative (RSGI) Submitted (FEB-2009) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 638-785. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF506799 mRNA. Translation: AAO15881.1. AK296323 mRNA. Translation: BAG59017.1. AC020894 Genomic DNA. No translation available. AC026689 Genomic DNA. No translation available. BX640827 mRNA. Translation: CAE45903.1. AB020676 mRNA. Translation: BAA74892.1. AF530058 mRNA. Translation: AAQ09942.1. AY189820 mRNA. Translation: AAO73817.1. BC004394 mRNA. Translation: AAH04394.1. BC017746 mRNA. Translation: AAH17746.1. | ||||||||||||
| IPI | IPI00217340. IPI00761080. | ||||||||||||
| RefSeq | NP_001155133.1. NM_001161661.1. NP_001155134.1. NM_001161662.1. NP_056053.1. NM_015238.2. | ||||||||||||
| UniGene | Hs.484047. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q8IX03. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-35287N. | ||||||||||||
| IntAct | Q8IX03. 6 interactions. | ||||||||||||
| MINT | MINT-1405937. | ||||||||||||
| STRING | 9606.ENSP00000265293. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q8IX03. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 74714457. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q8IX03. | ||||||||||||
| PRIDE | Q8IX03. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 23286. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000265293; ENSP00000265293; ENSG00000113645. ENST00000521089; ENSP00000427772; ENSG00000113645. | ||||||||||||
| GeneID | 23286. | ||||||||||||
| KEGG | hsa:23286. | ||||||||||||
| UCSC | uc003lzu.3. human. uc003lzv.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 23286. | ||||||||||||
| GeneCards | GC05P167652. | ||||||||||||
| HGNC | HGNC:29435. WWC1. | ||||||||||||
| HPA | HPA038016. HPA038017. | ||||||||||||
| MIM | 610533. gene. | ||||||||||||
| neXtProt | NX_Q8IX03. | ||||||||||||
| PharmGKB | PA143485670. | ||||||||||||
| HUGE | Search... | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG5021. | ||||||||||||
| HOGENOM | HOG000013211. | ||||||||||||
| HOVERGEN | HBG058082. | ||||||||||||
| KO | K16685. | ||||||||||||
| OMA | DPQVGDY. | ||||||||||||
| OrthoDB | EOG4H4632. | ||||||||||||
| PhylomeDB | Q8IX03. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_111102. Signal Transduction. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q8IX03. | ||||||||||||
| Bgee | Q8IX03. | ||||||||||||
| CleanEx | HS_WWC1. | ||||||||||||
| Genevestigator | Q8IX03. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR008973. C2_Ca/lipid-bd_dom_CaLB. IPR001202. WW_dom. [Graphical view] | ||||||||||||
| Pfam | PF00397. WW. 2 hits. [Graphical view] | ||||||||||||
| SMART | SM00456. WW. 2 hits. [Graphical view] | ||||||||||||
| SUPFAM | SSF49562. C2_CaLB. 1 hit. SSF51045. WW_Rsp5_WWP. 2 hits. | ||||||||||||
| PROSITE | PS50004. C2. False negative. PS01159. WW_DOMAIN_1. 1 hit. PS50020. WW_DOMAIN_2. 2 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | Q8IX03. | ||||||||||||
| GenomeRNAi | 23286. | ||||||||||||
| NextBio | 45094. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | KIBRA_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q8IX03 Secondary accession number(s): B4DK05 Q9BT29 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
